Moberg Pharma AB (publ) banner

Moberg Pharma AB (publ)
STO:MOB

Watchlist Manager
Moberg Pharma AB (publ) Logo
Moberg Pharma AB (publ)
STO:MOB
Watchlist
Price: 10.35 SEK 3.19% Market Closed
Market Cap: kr504.1m

Profitability Summary

Moberg Pharma AB (publ)'s profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Moberg Pharma AB (publ)

Margins Comparison
Moberg Pharma AB (publ) Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
SE
Moberg Pharma AB (publ)
STO:MOB
486.5m SEK
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
963B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
599.3B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
288.1B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
250B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
237.1B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
300.9B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
155.1B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.7B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Moberg Pharma AB (publ) Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SE
Moberg Pharma AB (publ)
STO:MOB
486.5m SEK
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
963B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
599.3B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
288.1B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
250B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
237.1B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
300.9B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
155.1B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.7B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Moberg Pharma AB (publ)

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett